GCC Hematology Expert Forum

Hematology-Live > Malignant > Leukemia
GCC Hematology Expert Forum
23
Dec
Real World Evidence in CLL
24
Jul
Current View on CLL 1st Line Treatment: In-Depth CLL Case Discussions and Fixed Duration Treatment Strategies
17
Jul
Management of high dose of methotrexate
14
Jun
Acute Lymphoblastic Leukemia: Hematology Journal Club 4.0
05
Apr

This journal club was a scientific-educational activity discussing the last updated and key points on Management of Acute Lymphoblastic Leukemia.

Minimal Residual Diseases (MRD): Hematology Journal Club 2
04
Apr

This journal club was a scientific-educational activity discussing data from BLAST trial, reflecting on the role of achieving and sustaining Minimal Residual Disease negativity status. The Role of Blinatumomab in managing Minimal Residual Disease (MRD) in B-Cell Acute Lymphoblastic Leukemia (B-ALL). One of its key goals was to share clinical experience on the use of […]

How to Optimise the Treatment of CLL Patients in Light of ASH 2020 Update
26
Mar

Speaker: Dr. Carolina Moreno Affiliations: Associate Progessor of Medicine, Autonomous Univeristy of Barcelona, Senior Consultant, Department of Hematology, Hospital de Saint Paul Santa Creu, Spain.   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

DLBCL: The Role of Biosimilar Rituximab
26
Mar

Speaker: Dr. Khalil Al Farsi Affiliations: Senior Consultant in the Hematology/BMT Department, Sultan Qaboos University Hospital, Muscat, Oman   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

Advances in the Management of pH-Positive Leukemia
26
Mar

Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

Updates in the Management of Chronic Lymphocytic Leukemia
26
Mar

Speaker: Dr. John M. Pagel Affiliations: Chief of Hematologic Malignancies, Swedish Cancer Institute, United States   This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

eaccme

Accreditation Statement

The Hematology Live Online Education, made available on https://hematologylive.online/ and organized by Meeting Minds Experts, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

 

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMSEACCME website have formally been accredited.

 

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.